• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院再入院减少计划对医院再入院率和死亡率的影响。

Effect of Hospital Readmission Reduction Program on Hospital Readmissions and Mortality Rates.

作者信息

Samarghandi Arash, Qayyum Rehan

机构信息

Division of Hospital Medicine, Virginia Commonwealth University (VCU) School of Medicine, Richmond, Virginia.

出版信息

J Hosp Med. 2019 Sep 18;14:E25-E30. doi: 10.12788/jhm.3302.

DOI:10.12788/jhm.3302
PMID:31532747
Abstract

RATIONALE

Although the Hospital Readmission Reduction Program (HRRP) has reduced the 30-day readmission rates for patients with chronic obstructive pulmonary disease (COPD) across hospitals, the effect of HRRP on hospital mortality remains unknown. Therefore, we examined the association between hospital readmissions and mortality rates for patients discharged with acute exacerbation of COPD (AECOPD).

METHOD

The all-cause hospital-specific 30-day risk-standardized mortality rate (RSMR) and the 30-day risk-standardized readmission rate (RSRR) for patients with COPD from 2010 to 2017 were obtained from the Hospital Compare website. Hospital service area (HSA) information was obtained from the Dartmouth Atlas of Healthcare. The longitudinal relationship between the mortality and readmission rates of a hospital was assessed using mixed linear models.

RESULTS

Of the 3,685 hospitals analyzed, the unadjusted mean RSMRs increased from 7.8% to 8.4% during the study period at a yearly rate of 0.13 (95% CI = 0.12 to 0.14; P < .001), whereas the mean RSRRs declined from 20.7% to 19.6%. When examined according to the baseline readmission rate and interaction with time, each 1% higher-than-baseline readmission rate was associated with a smaller increase in mortality rate by 0.015% (95% CI = -0.02 to -0.01; P < .0001). Inclusion of change in readmissions in the model showed that each 1% decrease in readmission rate was associated with 0.04% (95% CI = -0.01 to -0.06; P = .008) increase in mortality.

CONCLUSION

This hospital-level analysis of AECOPD showed that although the 30-day all-cause readmission rates declined, the mortality rates increased. Hospitals with lower readmission rates had higher mortality rates over time.

摘要

原理

尽管医院再入院率降低计划(HRRP)已降低了各医院慢性阻塞性肺疾病(COPD)患者的30天再入院率,但HRRP对医院死亡率的影响仍不明确。因此,我们研究了因慢性阻塞性肺疾病急性加重(AECOPD)出院患者的医院再入院率与死亡率之间的关联。

方法

从医院比较网站获取2010年至2017年COPD患者的全因医院特定30天风险标准化死亡率(RSMR)和30天风险标准化再入院率(RSRR)。医院服务区(HSA)信息来自达特茅斯医疗地图集。使用混合线性模型评估医院死亡率和再入院率之间的纵向关系。

结果

在分析的3685家医院中,研究期间未调整的平均RSMR从7.8%上升至8.4%,年增长率为0.13(95%CI=0.12至0.14;P<.001),而平均RSRR从20.7%降至19.6%。根据基线再入院率并结合时间进行分析时,再入院率比基线每高1%,死亡率的增幅就会小0.015%(95%CI=-0.02至-0.01;P<.0001)。模型中纳入再入院率的变化后显示,再入院率每降低1%,死亡率就会增加0.04%(95%CI=-0.01至-0.06;P=.008)。

结论

这项针对AECOPD的医院层面分析表明,尽管30天全因再入院率有所下降,但死亡率却有所上升。随着时间的推移,再入院率较低的医院死亡率较高。

相似文献

1
Effect of Hospital Readmission Reduction Program on Hospital Readmissions and Mortality Rates.医院再入院减少计划对医院再入院率和死亡率的影响。
J Hosp Med. 2019 Sep 18;14:E25-E30. doi: 10.12788/jhm.3302.
2
Association of Do-Not-Resuscitate Patient Case Mix With Publicly Reported Risk-Standardized Hospital Mortality and Readmission Rates.不复苏患者病例组合与公开报告的风险标准化医院死亡率和再入院率的关联。
JAMA Netw Open. 2020 Jul 1;3(7):e2010383. doi: 10.1001/jamanetworkopen.2020.10383.
3
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.医院再入院率降低计划实施与心力衰竭患者再入院和死亡率结局的关联。
JAMA Cardiol. 2018 Jan 1;3(1):44-53. doi: 10.1001/jamacardio.2017.4265.
4
Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.再入院减少计划:慢性阻塞性肺疾病的死亡率和再入院率。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):437-446. doi: 10.1164/rccm.202002-0310OC.
5
Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia.急性心肌梗死、心力衰竭或肺炎患者住院的再入院率与死亡率之间的关系。
JAMA. 2013 Feb 13;309(6):587-93. doi: 10.1001/jama.2013.333.
6
Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.在 Medicare 受益人群中,急性心肌梗死后 30 天再入院率和死亡率的种族差异的时间趋势。
JAMA Cardiol. 2020 Feb 1;5(2):136-145. doi: 10.1001/jamacardio.2019.4845.
7
Regression to the Mean in the Medicare Hospital Readmissions Reduction Program.医疗保险医院再入院减少计划中的均值回归
JAMA Intern Med. 2019 Sep 1;179(9):1167-1173. doi: 10.1001/jamainternmed.2019.1004.
8
Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.医疗保险医院再入院率降低计划中的经济激励与医院再入院绩效之间的关联。
JAMA Netw Open. 2020 Apr 1;3(4):e202044. doi: 10.1001/jamanetworkopen.2020.2044.
9
Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.医院再入院率降低计划下的医院处罚状态与目标及非目标病症再入院率之间的关联
JAMA. 2016 Dec 27;316(24):2647-2656. doi: 10.1001/jama.2016.18533.
10
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.2009 年至 2014 年佛罗里达州慢性阻塞性肺疾病(COPD)患者再入院率、住院费用和死亡率趋势。
Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.

引用本文的文献

1
Evaluating Quality of Care for Patients with Asthma in the Readmission Penalty Era.评估再入院惩罚时代哮喘患者的医疗质量。
Ann Am Thorac Soc. 2024 Aug;21(8):1166-1175. doi: 10.1513/AnnalsATS.202311-928OC.
2
Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.人口健康住院医疗保险优势计划药剂师干预对医院再入院的影响:一项准实验对照研究。
J Manag Care Spec Pharm. 2023 Mar;29(3):266-275. doi: 10.18553/jmcp.2023.29.3.266.
3
Yet Another Crack in the Facade of the Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program for Chronic Obstructive Pulmonary Disease.
医疗保险和医疗补助服务中心慢性阻塞性肺疾病医院再入院减少计划表面的又一道裂痕。
Am J Respir Crit Care Med. 2023 Jan 1;207(1):2-4. doi: 10.1164/rccm.202208-1551ED.
4
Time to Revisit the Hospital Readmissions Reduction Program for Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations.是时候重新审视慢性阻塞性肺疾病急性加重住院患者的医院再入院减少计划了。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):403-404. doi: 10.1164/rccm.202009-3392ED.
5
Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.再入院减少计划:慢性阻塞性肺疾病的死亡率和再入院率。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):437-446. doi: 10.1164/rccm.202002-0310OC.
6
Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.住院患者再入院率降低计划下的慢性阻塞性肺疾病再入院率:一项中断时间序列分析。
J Gen Intern Med. 2020 Dec;35(12):3581-3590. doi: 10.1007/s11606-020-05958-0. Epub 2020 Jun 17.